KWB Wealth’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,200
Closed -$466K 152
2024
Q4
$466K Sell
3,200
-945
-23% -$133K 0.06% 92
2024
Q3
$569K Buy
4,145
+329
+9% +$47.6K 0.07% 77
2024
Q2
$524K Hold
3,816
0.07% 77
2024
Q1
$524K Buy
+3,816
New +$521K 0.07% 77

Other funds holding IBB

KWB Wealth's IBB Position: Q1 2025 in Review

KWB Wealth sold out of iShares Biotechnology ETF (IBB) in Q1 2025, closing a stake of 3,200 shares — an estimated $466K sold.

KWB Wealth first reported a position in IBB in Q1 2024 and held it in 4 quarters. The position peaked at $569K in Q3 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.

  • KWB Wealth reported no remaining iShares Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • KWB Wealth sold 3,200 iShares Biotechnology ETF shares in Q1 2025, an estimated $466K.
  • KWB Wealth first reported a position in iShares Biotechnology ETF in Q1 2024 and held it in 4 quarters.
  • KWB Wealth's iShares Biotechnology ETF position peaked at $569K in Q3 2024.
  • 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.

Based on KWB Wealth's 13F filing for Q1 2025, filed 10 Apr 2025.